JP7178370B2 - 適合可能な標的グルコースレベルを用いる基礎タイトレーション - Google Patents

適合可能な標的グルコースレベルを用いる基礎タイトレーション Download PDF

Info

Publication number
JP7178370B2
JP7178370B2 JP2019568352A JP2019568352A JP7178370B2 JP 7178370 B2 JP7178370 B2 JP 7178370B2 JP 2019568352 A JP2019568352 A JP 2019568352A JP 2019568352 A JP2019568352 A JP 2019568352A JP 7178370 B2 JP7178370 B2 JP 7178370B2
Authority
JP
Japan
Prior art keywords
glucose
titration
insulin
timeframe
measurements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019568352A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2018228932A5 (https=
JP2020524844A (ja
JP2020524844A5 (https=
Inventor
ティナ ビョーク アラドッティル，
ヘンリク ベントスン，
モーテン リンド ジェンセン，
ピート ブロックマイヤー，
Original Assignee
ノボ・ノルデイスク・エー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノボ・ノルデイスク・エー／エス filed Critical ノボ・ノルデイスク・エー／エス
Priority claimed from PCT/EP2018/065126 external-priority patent/WO2018228932A1/en
Publication of JP2020524844A publication Critical patent/JP2020524844A/ja
Priority to JP2022044006A priority Critical patent/JP7389834B2/ja
Publication of JPWO2018228932A5 publication Critical patent/JPWO2018228932A5/ja
Publication of JP2020524844A5 publication Critical patent/JP2020524844A5/ja
Application granted granted Critical
Publication of JP7178370B2 publication Critical patent/JP7178370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or Bluetooth®
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
JP2019568352A 2017-06-15 2018-06-08 適合可能な標的グルコースレベルを用いる基礎タイトレーション Active JP7178370B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022044006A JP7389834B2 (ja) 2017-06-15 2022-03-18 適合可能な標的グルコースレベルを用いる基礎タイトレーション

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201762520139P 2017-06-15 2017-06-15
US62/520,139 2017-06-15
US201762522811P 2017-06-21 2017-06-21
US62/522,811 2017-06-21
EP17178877.1 2017-06-29
EP17178877 2017-06-29
EP17190146 2017-09-08
EP17190146.5 2017-09-08
PCT/EP2018/065126 WO2018228932A1 (en) 2017-06-15 2018-06-08 Basal titration with adaptive target glucose level

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022044006A Division JP7389834B2 (ja) 2017-06-15 2022-03-18 適合可能な標的グルコースレベルを用いる基礎タイトレーション

Publications (4)

Publication Number Publication Date
JP2020524844A JP2020524844A (ja) 2020-08-20
JPWO2018228932A5 JPWO2018228932A5 (https=) 2022-03-29
JP2020524844A5 JP2020524844A5 (https=) 2022-03-29
JP7178370B2 true JP7178370B2 (ja) 2022-11-25

Family

ID=62492661

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019568352A Active JP7178370B2 (ja) 2017-06-15 2018-06-08 適合可能な標的グルコースレベルを用いる基礎タイトレーション
JP2022044006A Active JP7389834B2 (ja) 2017-06-15 2022-03-18 適合可能な標的グルコースレベルを用いる基礎タイトレーション

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022044006A Active JP7389834B2 (ja) 2017-06-15 2022-03-18 適合可能な標的グルコースレベルを用いる基礎タイトレーション

Country Status (5)

Country Link
US (2) US11298461B2 (https=)
EP (2) EP3758008A1 (https=)
JP (2) JP7178370B2 (https=)
CN (2) CN117912631A (https=)
MA (1) MA49422A (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3826700A1 (en) * 2018-07-26 2021-06-02 Sanofi Method of adjusting medication doses
AU2023260398A1 (en) 2022-04-26 2024-11-21 Dexcom, Inc. System and method for titrating basal insulin doses
WO2024192362A1 (en) * 2023-03-16 2024-09-19 University Of Virginia Method for mitigating hypoglycemia rebound in an automated insulin delivery system
JPWO2024214253A1 (https=) * 2023-04-13 2024-10-17
WO2025090855A1 (en) * 2023-10-26 2025-05-01 University Of Virginia Patent Foundation Targeted basal insulin titration using sparse and dense glucose measurements

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531885A (ja) 1998-12-02 2002-09-24 ヤスカワエシエド テクノロジー リミテッド 改良型サーボ機構制御システムおよび方法
JP2005326943A (ja) 2004-05-12 2005-11-24 Ataru Okumura 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
JP2016517601A (ja) 2013-03-15 2016-06-16 アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． 検体モニタリング装置と関連づけられた装置、システム、および方法、並びにそれらを組み込んだ装置

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6923763B1 (en) 1999-08-23 2005-08-02 University Of Virginia Patent Foundation Method and apparatus for predicting the risk of hypoglycemia
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
US20050065760A1 (en) * 2003-09-23 2005-03-24 Robert Murtfeldt Method for advising patients concerning doses of insulin
US20070092888A1 (en) 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US7509156B2 (en) * 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
DK1972270T3 (da) 2007-03-23 2011-01-24 Hoffmann La Roche Fremgangsmåde og glucoseovervågningssystem til overvågning af individuelt metabolisk respons
EP2156684A4 (en) 2007-05-14 2012-10-24 Abbott Diabetes Care Inc METHOD AND DEVICE FOR PROVIDING DATA PROCESSING AND CONTROL IN A MEDICAL COMMUNICATION SYSTEM
EP4159114B1 (en) * 2007-10-09 2024-04-10 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
EP2245568A4 (en) 2008-02-20 2012-12-05 Univ Mcmaster EXPERIMENTAL SYSTEM FOR DETERMINING THE RESPONSE OF PATIENTS TO TREATMENT
PT2260423T (pt) 2008-04-04 2018-05-30 Hygieia Inc Aparelho para optimizar o regime de dosagem de insulina a um paciente
US9220456B2 (en) * 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
TWI394580B (zh) * 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
US20100256047A1 (en) * 2009-04-03 2010-10-07 Lifescan, Inc. Analyte Measurement and Management Device and Associated Methods
US8175812B2 (en) 2008-06-25 2012-05-08 Roche Diagnostics Operations, Inc. Method, system, and computer program product for calculating daily weighted averages of glucose measurements (or derived quantities) with time-based weights
WO2010089307A1 (en) * 2009-02-04 2010-08-12 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing information for glycemic control
US8562587B2 (en) 2009-02-25 2013-10-22 University Of Virginia Patent Foundation CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery
JP5654587B2 (ja) 2009-06-30 2015-01-14 ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． 基礎インスリン療法を算出する分析物試験方法及び装置
WO2011084208A1 (en) 2009-12-21 2011-07-14 Stc.Unm System and methods for estimating hba1c, treatment response, and hypoglycemia risk using self-monitoring of blood glucose data
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
WO2012122520A1 (en) 2011-03-10 2012-09-13 Abbott Diabetes Care Inc. Multi-function analyte monitor device and methods of use
RU2602040C2 (ru) 2011-08-26 2016-11-10 Университи Оф Вирджиния Патент Фоундэйшион Способ, система и машиночитаемый носитель для адаптационного рекомендательного контроля сахарного диабета
TW201318602A (zh) * 2011-11-14 2013-05-16 Joinsoon Medical Technology Co Ltd 具胰島素參數之血糖檢測統計方法及其血糖檢測機
TW201333870A (zh) * 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US9227014B2 (en) 2013-02-07 2016-01-05 The Board Of Trustees Of The Laland Stanford Junior University Kalman filter based on-off switch for insulin pump
EP4420603A3 (en) 2013-03-15 2024-11-20 Abbott Diabetes Care, Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US20150006192A1 (en) 2013-06-26 2015-01-01 WellDoc, Inc. Systems and methods for clinical decision-making
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
WO2015128740A2 (en) 2014-02-28 2015-09-03 Eco-Fusion Systems for predicting hypoglycemia and methods of use thereof
US10722650B2 (en) 2014-03-28 2020-07-28 Roche Diabetes Care, Inc. System and method for adjusting therapy based on risk associated with a glucose state
GB201407896D0 (en) * 2014-05-05 2014-06-18 Joanneum Res Forschungsgmbh Insulin dosage proposal system
US10617363B2 (en) 2015-04-02 2020-04-14 Roche Diabetes Care, Inc. Methods and systems for analyzing glucose data measured from a person having diabetes
US10657224B2 (en) 2015-09-25 2020-05-19 Accenture Global Solutions Limited Monitoring and treatment dosage prediction system
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US10304315B2 (en) 2016-06-09 2019-05-28 Amp Llc Systems and methods for health monitoring and providing emergency support
US20190287645A1 (en) 2016-07-06 2019-09-19 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
US10971030B2 (en) 2017-01-26 2021-04-06 International Business Machines Corporation Remote physical training

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531885A (ja) 1998-12-02 2002-09-24 ヤスカワエシエド テクノロジー リミテッド 改良型サーボ機構制御システムおよび方法
JP2005326943A (ja) 2004-05-12 2005-11-24 Ataru Okumura 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
JP2016517601A (ja) 2013-03-15 2016-06-16 アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． 検体モニタリング装置と関連づけられた装置、システム、および方法、並びにそれらを組み込んだ装置

Also Published As

Publication number Publication date
EP3639268B1 (en) 2024-10-09
EP3758008A1 (en) 2020-12-30
CN117912631A (zh) 2024-04-19
JP2022095682A (ja) 2022-06-28
JP7389834B2 (ja) 2023-11-30
EP3639268A1 (en) 2020-04-22
US12109392B2 (en) 2024-10-08
US20220184310A1 (en) 2022-06-16
US20210146046A1 (en) 2021-05-20
US11298461B2 (en) 2022-04-12
MA49422A (fr) 2020-04-22
CN110741438B (zh) 2023-12-29
JP2020524844A (ja) 2020-08-20
CN110741438A (zh) 2020-01-31

Similar Documents

Publication Publication Date Title
US11373746B2 (en) Basal titration with adaptive target glucose level
JP7389834B2 (ja) 適合可能な標的グルコースレベルを用いる基礎タイトレーション
CN109690685B (zh) 用于确定胰岛素敏感性的系统和方法
US11195607B2 (en) Starter kit for basal rate titration
US11282598B2 (en) Starter kit for basal insulin titration
US11631486B2 (en) Systems and methods for optimization of bolus timing relative to meal events
US20210287775A1 (en) Systems and methods for adjusting basal administration timing
EP3500962B1 (en) System and method for adjusting a basal/bolus ratio in an insulin regimen
CN109416945B (zh) 用于基于葡萄糖测量结果和胰岛素笔数据的胰岛素治疗的方案遵守措施
WO2018228932A1 (en) Basal titration with adaptive target glucose level

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210518

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220318

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221005

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221025

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221114

R150 Certificate of patent or registration of utility model

Ref document number: 7178370

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150